<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37338613</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.</ArticleTitle><Pagination><StartPage>4868</StartPage><EndPage>4875</EndPage><MedlinePgn>4868-4875</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-11827-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Upper motor neuron (UMN) and lower motor neuron (LMN) involvement represent the core clinical features of amyotrophic lateral sclerosis (ALS). Several studies divided patients into prevalent UMN and LMN impairment phenotypes to investigate the association between motor systems impairments and ALS clinical course. However, this distinction was somehow heterogeneous and significantly affected the comparability across studies.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This study aimed to investigate whether patients spontaneously segregate based on the extent of UMN and LMN involvement without a-priori categorization and to identify potential clinical and prognostic features of different clusters.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eighty-eight consecutive spinal-onset ALS patients were referred to an ALS tertiary center between 2015 and 2022. UMN and LMN burden was assessed with the Penn Upper Motor Neuron scale (PUMNS) and the Devine score, respectively. PUMNS and LMN scores were normalized into 0-1 and analyzed using a two-step cluster analysis and the Euclidean distance measure. The Bayesian Information Criterion was used to determine the cluster number. Demographic and clinical variables were tested for differences among the clusters.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three distinct clusters emerged at cluster analysis. Patients in "cluster-1" showed moderate UMN and severe LMN involvement, corresponding to the typical ALS phenotype. Patients in "cluster-2" showed mild LMN and severe UMN damage, corresponding to a predominant UMN phenotype, while "cluster-3" patients showed mild UMN and moderate LMN damage, corresponding to a predominant LMN phenotype. Patients in "cluster-1" and "cluster-2" showed a higher prevalence of definite ALS than those in "cluster-3" (61% and 46 vs 9%, p&#x2009;&lt;&#x2009;0.001). "Cluster-1" patients had a lower median ALSFRS-r score compared to both "cluster-2" and 3 patients (27 vs 40 and 35,&#x2009;&lt;&#x2009;0.001). "Cluster-1" (HR: 8.5; 95% CI 2.1-35.1 and p&#x2009;=&#x2009;0.003) and 3 (HR: 3.2; 95% CI 1.1-9.1; p&#x2009;=&#x2009;0.03) were associated with shorter survival than those in "cluster-2".</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Spinal-onset ALS can be categorized into three groups according to LMN and UMN burden. The UMN burden is related to higher diagnostic certainty and broader disease spread, while LMN involvement is associated with higher disease severity and shorter survival.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Milella</LastName><ForeName>Giammarco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zoccolella</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4037-7630</Identifier><AffiliationInfo><Affiliation>Neurology Unit, ASL Bari, San Paolo Hospital, Bari, Italy. stefzoc@hotmail.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy. stefzoc@hotmail.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giugno</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filardi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigro</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tafuri</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamburrino</LastName><ForeName>Ludovica</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnoni</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logroscino</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Diseases and the Aging Brain at Pia Fondazione "Card. G. Panico", University of Bari, Tricase (Lecce), Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cluster analysis</Keyword><Keyword MajorTopicYN="N">Lower motor neuron</Keyword><Keyword MajorTopicYN="N">Upper motor neuron</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37338613</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11827-7</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-11827-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124:96&#x2013;107. https://doi.org/10.1016/0022-510X(94)90191-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord 1:293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E, Doretti A, Scheveger F et al (2023) Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis. J Neurol 270:511&#x2013;518. https://doi.org/10.1007/s00415-022-11404-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11404-4</ArticleId><ArticleId IdType="pubmed">36183286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Introna A, Milella G et al (2021) Subclinical upper motor neuron involvement at the diagnosis may predict disease progression in a cohort of lower motor neuron syndromes from Southern Italy. J Neurol Sci 425:117392. https://doi.org/10.1016/j.jns.2021.117392</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117392</ArticleId><ArticleId IdType="pubmed">33838499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Mastronardi A, Scarafino A et al (2020) Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype. J Neurol. https://doi.org/10.1007/s00415-020-10073-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10073-5</ArticleId><ArticleId IdType="pubmed">32676769</ArticleId><ArticleId IdType="pmc">7674351</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Ballard E, O&#x2019;Rourke P et al (2016) Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener 17:184&#x2013;190. https://doi.org/10.3109/21678421.2015.1125502</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1125502</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromicho M, Figueiral M, Uysal H et al (2020) Spreading in ALS: the relative impact of upper and lower motor neuron involvement. Ann Clin Transl Neurol 7:1181&#x2013;1192. https://doi.org/10.1002/acn3.51098</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51098</ArticleId><ArticleId IdType="pubmed">32558369</ArticleId><ArticleId IdType="pmc">7359118</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura-Kiyono C, Kimura F, Ishida S et al (2011) Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:1244&#x2013;1249. https://doi.org/10.1136/jnnp-2011-300141</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300141</ArticleId><ArticleId IdType="pubmed">21921087</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C et al (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82:740&#x2013;746. https://doi.org/10.1136/jnnp.2010.235952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieve SM, Menon P, Korgaonkar MS et al (2015) Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. Amyotroph Lateral Scler Front Degener 17:85&#x2013;92. https://doi.org/10.3109/21678421.2015.1074707</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1074707</ArticleId></ArticleIdList></Reference><Reference><Citation>Distaso E, Milella G, Mezzapesa DM et al (2021) Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone. J Neurol 268:3307&#x2013;3315. https://doi.org/10.1007/s00415-021-10495-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10495-9</ArticleId><ArticleId IdType="pubmed">33655342</ArticleId><ArticleId IdType="pmc">8357666</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Edmundson C, Dahodwala N, Elman L (2020) Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle Nerve 61:508&#x2013;511. https://doi.org/10.1002/mus.26764</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26764</ArticleId><ArticleId IdType="pubmed">31743477</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847&#x2013;852. https://doi.org/10.1093/brain/awr351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId><ArticleId IdType="pmc">3286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Al Khleifat A, Fang T, Al-Chalabi A (2019) A standard operating procedure for King&#x2019;s ALS clinical staging. Amyotroph Lateral Scler Front Degener 20:159&#x2013;164. https://doi.org/10.1080/21678421.2018.1556696</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1556696</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Copetti M, Panza F et al (2016) Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study. Eur J Neurol 23:1117&#x2013;1125. https://doi.org/10.1111/ene.12994</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12994</ArticleId><ArticleId IdType="pubmed">27016147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman L, Rousseeuw PJ (1990) Finding groups in data: an introduction to cluster analysis. Wiley, New York, pp 320&#x2013;331</Citation></Reference><Reference><Citation>Ravits J (2014) Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis. Exp Neurol 262(1):121&#x2013;126. https://doi.org/10.1016/j.expneurol.2014.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.021</ArticleId><ArticleId IdType="pubmed">25108067</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Kiernan MC, Heggie S et al (2014) Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons. Amyotroph Lateral Scler Front Degener 15:481&#x2013;487. https://doi.org/10.3109/21678421.2014.906617</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.906617</ArticleId></ArticleIdList></Reference><Reference><Citation>Milella G, Zoccolella S, Urso D et al (2023) Different patterns of spreading direction and motor neurons involvement in a cohort of limb-onset amyotrophic lateral sclerosis patients from Southern Italy: Potential implication on disease course or progression? Brain Behav. https://doi.org/10.1002/brb3.2899</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2899</ArticleId><ArticleId IdType="pubmed">37208847</ArticleId><ArticleId IdType="pmc">10275554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR (2009) ALS motor phenotype heterogeneity, focality, and spread. Neurology 73:805&#x2013;811. https://doi.org/10.1212/WNL.0b013e3181b6bbbd</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId><ArticleId IdType="pmc">2739608</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli EG, Riva N, Rancoita PMV et al (2020) Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis. NeuroImage Clin 27:102315. https://doi.org/10.1016/j.nicl.2020.102315</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102315</ArticleId><ArticleId IdType="pubmed">32593977</ArticleId><ArticleId IdType="pmc">7327879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth AM, Khomenko A, Baldaranov D et al (2018) Combinatory biomarker use of cortical thickness, MUNIX, and ALSFRS-R at baseline and in longitudinal courses of individual patients with amyotrophic lateral sclerosis. Front Neurol 9:614. https://doi.org/10.3389/fneur.2018.00614</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00614</ArticleId><ArticleId IdType="pubmed">30104996</ArticleId><ArticleId IdType="pmc">6077217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakken O, Meyer HE, Stigum H, Holm&#xf8;y T (2019) High BMI is associated with low ALS risk: a population-based study. Neurology 93:e424&#x2013;e432. https://doi.org/10.1212/WNL.0000000000007861</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007861</ArticleId><ArticleId IdType="pubmed">31243073</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Beard JD, Umbach DM et al (2017) Body mass index and amyotrophic lateral sclerosis: a study of US military veterans. Am J Epidemiol 185:362&#x2013;371. https://doi.org/10.1093/aje/kww140</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kww140</ArticleId><ArticleId IdType="pubmed">28158443</ArticleId><ArticleId IdType="pmc">5860019</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Pinto S, Swash M (2010) Association of paraspinal and diaphragm denervation in ALS. Amyotroph Lateral Scler 11:63&#x2013;66. https://doi.org/10.3109/17482960902730080</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902730080</ArticleId><ArticleId IdType="pubmed">19533450</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Pinto A, de Carvalho M (2012) Phrenic nerve studies predict survival in amyotrophic lateral sclerosis. Clin Neurophysiol 123:2454&#x2013;2459. https://doi.org/10.1016/j.clinph.2012.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2012.05.012</ArticleId><ArticleId IdType="pubmed">22762911</ArticleId></ArticleIdList></Reference><Reference><Citation>Similowski T, Attali V, Bensimon G et al (2000) Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J 15:332&#x2013;337. https://doi.org/10.1034/j.1399-3003.2000.15b19.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3003.2000.15b19.x</ArticleId><ArticleId IdType="pubmed">10706501</ArticleId></ArticleIdList></Reference><Reference><Citation>Schito P, Ceccardi G, Calvo A et al (2020) Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study. J Neurol Neurosurg Psychiatry 91:1001&#x2013;1003. https://doi.org/10.1136/jnnp-2020-323542</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323542</ArticleId><ArticleId IdType="pubmed">32651246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB et al (2006) The natural history of primary lateral sclerosis. Neurology 66:647&#x2013;653. https://doi.org/10.1212/01.wnl.0000200962.94777.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000200962.94777.71</ArticleId><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Milella G, Introna A, Mezzapesa DM et al (2023) Clinical profiles and patterns of neurodegeneration in amyotrophic lateral sclerosis: a cluster-based approach based on MR imaging metrics. AJNR Am J Neuroradiol. https://doi.org/10.3174/ajnr.A7823</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A7823</ArticleId><ArticleId IdType="pubmed">36958798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Murad A, Lope J et al (2022) Clusters of anatomical disease-burden patterns in ALS: a data-driven approach confirms radiological subtypes. J Neurol. https://doi.org/10.1007/s00415-022-11081-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11081-3</ArticleId><ArticleId IdType="pubmed">35333981</ArticleId><ArticleId IdType="pmc">9294023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Plowman EK, Green JR et al (2019) Clinical Measures of Bulbar Dysfunction in ALS. Front Neurol 10:106. https://doi.org/10.3389/fneur.2019.00106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00106</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId><ArticleId IdType="pmc">6389633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>